Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists

• Egile Nagusiak: Denis Choquette (Egilea), Jonathan Chan (Egilea), Mohammad Bardi (Egilea), Carolyn Whiskin (Egilea), Gabriel Torani (Egilea), Brennan K. Smith (Egilea), Aaron Sihota (Egilea)
• Formatua: Liburua
• Argitaratua: Centro de Investigaciones y Publicaciones Farmaceuticas, 2021-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Recent approvals for novel agents such as the small molecule Janus kinase inhibitors (JAKi), combined with the advent of biosimilars has widened the gamut of available therapeutic options in the treatment of rheumatoid arthritis (RA). This combined with the introduction of mandatory non-...